C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis

Metabolic outcomes in type 1 diabetes remain suboptimal. Disease modifying therapy to prevent β-cell loss presents an alternative treatment framework but the effect on metabolic outcomes is unclear. We, therefore, aimed to define the relationship between insulin C-peptide as a marker of β-cell funct...

Full description

Bibliographic Details

Published in:	The lancet. Diabetes & endocrinology Vol. 11; no. 12; p. 915
Main Authors:	Taylor, Peter N, Collins, Kimberly S, Lam, Anna, Karpen, Stephen R, Greeno, Brianna, Walker, Frank, Lozano, Alejandro, Atabakhsh, Elnaz, Ahmed, Simi T, Marinac, Marjana, Latres, Esther, Senior, Peter A, Rigby, Mark, Gottlieb, Peter A, Dayan, Colin M
Format:	Journal Article
Language:	English
Published:	England 01.12.2023
Subjects:	Adult C-Peptide - therapeutic use Child Cross-Sectional Studies Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - drug therapy Glycated Hemoglobin Humans Hypoglycemic Agents - therapeutic use Insulin - therapeutic use
ISSN:	2213-8595, 2213-8595
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!